Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease - PubMed (original) (raw)

Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease

A Clements et al. J Neurochem. 1996 Feb.

Abstract

The fibrillogenic properties of Alzheimer's A beta peptides corresponding to residues 1-40 of the normal human sequence and to two mutant forms containing the replacement Ala21 to Gly or Glu22 to Gln were compared. At pH 7.4 and 37 degrees C the Gln22 peptide was found to aggregate and precipitate from solution faster than the normal A beta, whereas the Gly21 peptide aggregated much more slowly. Electron microscopy showed that the aggregates all had fibrillar structures. Circular dichroism spectra of these peptides revealed that aggregation of the normal and Gln22 sequences was associated with spectral changes consistent with a transformation from random coil to beta sheet, whereas the spectrum of the Gly21 peptide remained almost unchanged during a period in which little or no aggregation occurred. When immobilised by spotting onto nitrocellulose membranes the peptides bound similar amounts of the radioisotope 65Zn2+. Of several competing metal ions, tested at 20x the concentration of Zn2+, Cu2+ displaced > 95% of the radioactivity from all three peptides and Ni2+ produced >50% displacement in each case. Some other metal ions tested caused lesser displacement, but Fe2+ and Al3+ were without effect. In a saturation binding assay, a value of 3.2 microM was obtained for the binding of Zn2+ to A beta but our data provided no evidence for a reported higher affinity site (107 nM). The results suggest that the neuropathology associated with the Gly21 mutation is not due to enhanced fibrillogenic or different metal-binding properties of the peptide and that the binding of zinc to amyloid peptides is not a specific phenomenon.

PubMed Disclaimer

Cited by

Studies on the interactions of copper and zinc ions with β-amyloid peptides by a surface plasmon resonance biosensor.
Yao F, Zhang R, Tian H, Li X. Yao F, et al. Int J Mol Sci. 2012;13(9):11832-11843. doi: 10.3390/ijms130911832. Epub 2012 Sep 19. Int J Mol Sci. 2012. PMID: 23109885 Free PMC article.
A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease.
Lovell MA. Lovell MA. J Alzheimers Dis. 2009;16(3):471-83. doi: 10.3233/JAD-2009-0992. J Alzheimers Dis. 2009. PMID: 19276540 Free PMC article. Review.
Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease.
Leskovjan AC, Lanzirotti A, Miller LM. Leskovjan AC, et al. Neuroimage. 2009 Oct 1;47(4):1215-20. doi: 10.1016/j.neuroimage.2009.05.063. Epub 2009 May 28. Neuroimage. 2009. PMID: 19481608 Free PMC article.
Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.
Watson DJ, Selkoe DJ, Teplow DB. Watson DJ, et al. Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):703-9. Biochem J. 1999. PMID: 10359654 Free PMC article.
Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V, Leissring MA, Dolios G, Wang R, Selkoe DJ, Walsh DM. Betts V, et al. Neurobiol Dis. 2008 Sep;31(3):442-50. doi: 10.1016/j.nbd.2008.06.001. Epub 2008 Jun 17. Neurobiol Dis. 2008. PMID: 18602473 Free PMC article.

Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease - PubMed (original) (raw)